Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: Role of heparin-binding epidermal growth factor

Molecular Endocrinology

Volumn 18, Issue 8, 2004, Pages 2035-2048

  Shah, Bukhtiar H ^a   Yesilkaya, Akin ^b   Olivares Reyes, J Alberto ^c   Chen, Hung Dar ^a   Hunyady, László ^d   Catt, Kevin J ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b AKDENIZ UNIVERSITY   (Turkey)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CRM 197; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUTRALIZING ANTIBODY; PROTEIN INHIBITOR; PROTEIN S6; PROTEIN SHC; PROTEIN TYROSINE KINASE; S6 KINASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL STIMULATION; CELL TYPE; CERCOPITHECIDAE; EMBRYO; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EPIDERMAL GROWTH FACTOR; HUMANS; KINETICS; METALLOPROTEASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

ANIMALIA; CERCOPITHECIDAE;

EID: 3442884527     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0476     Document Type: Article

References (54)

1. Luttrell LM 2002 Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can J Physiol Pharmacol 80:375-382
2. Wetzker R, Bohmer FD 2003 Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4:651-657
3. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
4. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T 2000 International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
5. Unger T 2002 The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89:3A-9A
6. Shah BH, Catt KJ 2003 A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24:239-244
7. Shah BH, Catt KJ 2002 Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cδ, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. Mol Pharmacol 61:343-351
8. Yin G, Yan C, Berk BC 2003 Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35:780-783
9. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T 2001 Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease- dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276:7957-79562
10. Tian Y, Smith RD, Balla T, Catt KJ 1998 Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. Endocrinology 139:1801-1809
11. Turner NA, Ball SG, Balmforth AJ 2001 The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation. Cell Signal 13:269-277
12. Kramer HK, Onoprishvili I, Andria ML, Hanna K, Sheinkman K, Haddad LB, Simon EJ 2002 δ Opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol 2:5
13. Della Rocca GJ, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM 1999 Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 274:13978-13984
14. Hua H, Munk S, Whiteside CI 2003 Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol 284:F303-F312
15. Belcheva MM, Szucs M, Wang D, Sadee W, Coscia CJ 2001 μ-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847-33853
16. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ 2003 Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782-10787
17. Shah BH, Alberto Olivares-Reyes J, Yesilkaya A, Catt KJ 2002 Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes. Mol Endocrinol 16: 610-620
18. Seta K, Sadoshima J 2003 Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem 278:9019-9026
19. Shah BH, Soh JW, Catt KJ 2003 Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation. J Biol Chem 278:2866-2875
20. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
21. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttreli LM 2002 β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429-9436
22. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J 2002 Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556-564
23. Zhang J, Ferguson SS, Barak LS, Menard L, Caron MG 1996 Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J Biol Chem 271:18302-18305
24. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, Luttrell LM 2003 The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278: 6258-6267
25. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A 1999 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884-888
26. Reynolds CM, Eguchi S, Frank GD, Motley ED 2002 Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension 39:525-529
27. Mitamura T, Higashiyama S, Taniguchi N, Klagsbrun M, Mekada E 1995 Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem 270:1015-1019
28. Nakamura K, Mitamura T, Takahashi T, Kobayashi T, Mekada E 2000 Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J Biol Chem 275: 18284-18290
29. Shah BH, Farshori MP, Jambusaria A, Catt KJ 2003 Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 278:19118-19126
30. Doan TN, Ali MS, Bernstein KE 2001 Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling. J Biol Chem 276:20954-20958
31. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW 2001 Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:489-495
32. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, Hannan RD 2002 Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 90:135-142
33. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S 2002 Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8:35-40
34. Nose A, Mori Y, Uchiyama-Tanaka Y, Kishimoto N, Maruyama K, Matsubara H, Iwasaka T 2003 Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: involvement of HB-EGF and EGF receptor transactivation. Hypertens Res 26:67-73
35. Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Murasawa S, Mori Y, Kosaki A, Maruyama K, Masaki H, Shibasaki Y, Fujiyama S, Nose A, Iba O, Hasagawa T, Tateishi E, Higashiyama S, Iwasaka T 2001 Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int 60:2153-2163
36. Lin J, Freeman MR 2003 Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 54:1-7
37. Suarez C, Diaz-Torga G, Gonzalez-Iglesias A, Vela J, Mladovan A, Baldi A, Becu-Villalobos D 2003 Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells. Am J Physiol Endocrinol Metab 285:E645-E653
38. Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S 2003 Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol 196:370-377
39. Grewal JS, Luttrell LM, Raymond JR 2001 G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells. J Biol Chem 276:27335-27344
40. Saito Y, Berk BC 2001 Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33:3-7
41. Andresen BT, Linnoila JJ, Jackson EK, Romero GG 2003 Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension 41:781-786
42. Seals DF, Courtneidge SA 2003 The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7-30
43. Fujino T, Hasebe N, Fujita M, Takeuchi K, Kawabe J, Tobise K, Higashiyama S, Taniguchi N, Kikuchi K 1998 Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats. Cardiovasc Res 38:3653-3674
44. Tanaka N, Masamura K, Yoshida M, Kato M, Kawai Y, Miyamori I 2002 A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun 297:375-381
45. Spinale FG 2002 Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90: 520-530
46. Tyagi SC, Hoit BD 2002 Metalloproteinase in myocardial adaptation and maladaptation. J Cardiovasc Pharmacol Ther 7:241-246
47. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, Eguchi S 2002 Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 294:1023-1029
48. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI 2002 Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106: 909-912
49. Kao S, Jaiswal RK, Kolch W, Landreth GE 2001 Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 276:18169-18177
50. Miggin SM, Kinsella BT 2002 Regulation of extracellular signal-regulated kinase cascades by α- and β-isoforms of the human thromboxane A(2) receptor. Mol Pharmacol 61:817-831
51. Kiso S, Kawata S, Tamura S, Miyagawa J, Ito N, Tsushima H, Yamada A, Umeki S, Higashiyama S, Taniguchi N, Matsuzawa Y 1999 Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis. J Gastroenterol Hepatol 14:1203-1209
52. Weng YI, Shukla SD 2002 Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. Biochim Biophys Acta 1589:285-297
53. Hunyady L, Bor M, Balla T, Catt KJ 1994 Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem 269:31378-31382
54. 1 angiotensin receptor. J Cell Biol 157:1211-1222